Chiasma, Inc. (NASDAQ:CHMA) is scheduled to issue its quarterly earnings data before the market opens on Tuesday, August 8th. Analysts expect the company to announce earnings of ($0.23) per share for the quarter.

Chiasma (NASDAQ:CHMA) last posted its quarterly earnings results on Friday, May 5th. The biotechnology company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by $0.06. On average, analysts expect Chiasma to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Shares of Chiasma, Inc. (NASDAQ:CHMA) opened at 1.35 on Tuesday. Chiasma, Inc. has a 52-week low of $1.25 and a 52-week high of $3.71. The company’s market cap is $32.88 million. The stock has a 50 day moving average of $1.43 and a 200 day moving average of $1.60.

WARNING: “Chiasma, Inc. (NASDAQ:CHMA) Set to Announce Quarterly Earnings on Tuesday” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/08/01/chiasma-inc-nasdaqchma-set-to-announce-quarterly-earnings-on-tuesday.html.

About Chiasma

Chiasma, Inc is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using its Transient Permeability Enhancer (TPE) technology platform, the Company is developing oral therapies. The Company has completed a Phase III clinical trial of its TPE platform-based product candidate, oral octreotide capsules (trade named as MYCAPSSA) for the treatment of acromegaly, a condition that results in the body’s production of excess growth hormone.

Earnings History for Chiasma (NASDAQ:CHMA)

Receive News & Ratings for Chiasma Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chiasma Inc. and related companies with MarketBeat.com's FREE daily email newsletter.